Ignite Creation Date:
2025-12-24 @ 7:37 PM
Ignite Modification Date:
2025-12-25 @ 5:17 PM
Study NCT ID:
NCT03433703
Status:
TERMINATED
Last Update Posted:
2019-12-06
First Post:
2018-02-09
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Trial to Evaluate Safety and Efficacy of Treatment of Physician Choice (TPC) Following First-Line Treatment of Lenvatinib in Subjects With Unresectable Hepatocellular Carcinoma (uHCC)
Sponsor:
Eisai Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-04-26
Start Date Type:
ACTUAL
Primary Completion Date:
2019-01-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-01-07
Completion Date Type:
ACTUAL
First Submit Date:
2018-02-09
First Submit QC Date:
None
Study First Post Date:
2018-02-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2019-10-04
Results First Submit QC Date:
None
Results First Post Date:
2019-12-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-11-19
Last Update Post Date:
2019-12-06
Last Update Post Date Type:
ACTUAL